Indomethacin decreases insulin secretion by reducing KCa3. 1 as a biomarker of pancreatic tumor and causes apoptotic cell death

A Karatug Kacar - Journal of Biochemical and Molecular …, 2020 - Wiley Online Library
Insulinomas originate from pancreatic β cells and it is the most widely known tumor.
Indomethacin is a nonsteroidal anti‐inflammatory drug, which is used for blocking the …
被引用次数：7 相关文章

Indomethacin decreases insulin secretion by reducing KCa3. 1 as a biomarker of pancreatic tumor and causes apoptotic cell death.

Journal of Biochemical and Molecular Toxicology, 2020 - europepmc.org
Insulinomas originate from pancreatic β cells and it is the most widely known tumor.
Indomethacin is a nonsteroidal anti-inflammatory drug, which is used for blocking the …
[PDF] researchgate.net

[PDF][PDF] Indomethacin decreases insulin secretion by reducing KCa3. 1 as a biomarker of pancreatic tumor and causes apoptotic cell death

AK Kacar - researchgate.net
Insulinomas originate from pancreatic β cells and it is the most widely known tumor.
Indomethacin is a nonsteroidal anti‐inflammatory drug, which is used for blocking the …

Indomethacin decreases insulin secretion by reducing KCa3. 1 as a biomarker of pancreatic tumor and causes apoptotic cell death

AK Kacar - Journal of biochemical and molecular …, 2020 - pubmed.ncbi.nlm.nih.gov
Insulinomas originate from pancreatic β cells and it is the most widely known tumor.
Indomethacin is a nonsteroidal anti-inflammatory drug, which is used for blocking the …

Indomethacin decreases insulin secretion by reducing KCa3. 1 as a biomarker of pancreatic tumor and causes apoptotic cell death.

A Karatug Kacar - Journal of Biochemical & Molecular …, 2020 - search.ebscohost.com
Insulinomas originate from pancreatic β cells and it is the most widely known tumor.
Indomethacin is a nonsteroidal anti‐inflammatory drug, which is used for blocking the …